Association of low vitamin D levels with metabolic syndrome in hemodialysis patients

Hemodialysis International

Volumn 20, Issue 2, 2016, Pages 261-269

  Ahmadi, Farrokhlagha ^a   Damghani, Samaneh ^a   Lessan Pezeshki, Mahboob ^a   Razeghi, Effat ^a   Maziar, Sima ^b   Mahdavi Mazdeh, Mitra ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hemodialysis; Metabolic syndrome; Vitamin D deficiency; Vitamin D insufficiency

Indexed keywords

25 HYDROXYVITAMIN D; GLUCOSE; PARATHYROID HORMONE; VITAMIN D;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME IMMUNOASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; SEX DIFFERENCE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ADVERSE EFFECTS; CHRONIC KIDNEY FAILURE; COMPLICATION; METABOLISM; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RENAL DIALYSIS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84929849483     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/hdi.12316     Document Type: Article

References (40)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005; 365:1415-1428.
2. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation. 2004; 109:433-438.
3. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005; 112:3066-3072.
4. Malik S, Wong ND, Franklin SS, etal. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004; 110:1245-1250.
5. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004; 109:42-46.
6. Chen J, Muntner P, Hamm LL, etal. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med. 2004; 140:167-174.
7. Yaffe K, Kanaya A, Lindquist K, etal. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004; 292:2237-2242.
8. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF, Vitamin D. Deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008; 52:1949-1956.
9. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357:266-281.
10. Wang TJ, Pencina MJ, Booth SL, etal. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008; 117:503-511.
11. Dobnig H, Pilz S, Scharnagl H, etal. Independent association of low serum 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008; 168:1340-1349.
12. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med. 2008; 168:1174-1180.
13. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008; 168:1629-1637.
14. Martins D, Wolf M, Pan D, etal. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: Data from the third national health and nutrition examination survey. Arch Intern Med. 2007; 167:1159-1165.
15. Autier P, Gandini S. Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med. 2007; 167:1730-1737.
16. Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol. 2012; 109:359-363.
17. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum Vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005; 28:1228-1230.
18. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005; 28:2926-2932.
19. Forman JP, Giovannucci E, Holmes MD, etal. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007; 49:1063-1069.
20. Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr. 2004; 79:820-825.
21. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vázquez C, Escobar-Morreale HF. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007; 26:573-580.
22. Zittermann A, Gummert JF, Borgermann J. The role of vitamin D in dyslipidemia and cardiovascular disease. Curr Pharm Des. 2011; 17:933-942.
23. Valle ED, Negri AL, Aguirre C, Fradinger E, Zanchetta JR. Prevalence of 25 (OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int 2007; 11:315-321.
24. Alberti K, Zimmet P, Shaw J. Metabolic syndrome-A new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 2006; 23:469-480.
25. Esteghamati A, Ashraf H, Rashidi A, Meysamie A. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res Clin Pract. 2008; 82:104-107.
26. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42(4 Suppl 3):S1-S201.
27. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009; 32:1092-1097.
28. Young DO, Lund RJ, Haynatzki G, Dunlay RW. Prevalence of the metabolic syndrome in an incident dialysis population. Hemodial Int 2007; 11:86-95.
29. Ucar E, Huzmeli C, Guven O, etal. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions. Ren Fail. 2009; 31:221-228.
30. Johnson DW, Armstrong K, Campbell SB, etal. Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology 2007; 12:391-398.
31. Tsangalis G, Papaconstantinou S, Kosmadakis G, Valis D, Zerefos N. Prevalence of the metabolic syndrome in hemodialysis. Int J Artif Organs. 2007; 30:118-123.
32. Azimi-Nezhad M, Herbeth B, Siest G, etal. High prevalence of metabolic syndrome in Iran in comparison with France: What are the components that explain this? Metab Syndr Relat Disord 2012; 10:181-188.
33. Mozaffarian D, Abdollahi M, Campos H, Houshiarrad A, Willett WC. Consumption of trans fats and estimated effects on coronary heart disease in Iran. Eur J Clin Nutr. 2007; 61:1004-1010.
34. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J. 2008; 7:4.
35. Alemzadeh R, Kichler J. Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents. Metab Syndr Relat Disord 2012; 10:422-429.
36. Cheng SP, Liu CL, Liu TP, Hsu YC, Lee JJ. Association between parathyroid hormone levels and inflammatory markers among US adults. Mediators Inflamm. 2014; 2014:8.
37. Chiu KC, Chuang L-M, Lee NP, etal. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism. 2000; 49:1501-1505.
38. Pilz S, Tomaschitz A, März W, Cavalier E, Ritz E. Aldosterone and parathyroid hormone: A complex and clinically relevant relationship. Calcified Tissue Int. 2010; 87:373-374.
39. Reis JP, von Mühlen D, Miller ER. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol. 2008; 159:41-48.
40. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000; 72:690-693.